Fluidic Sciences Ltd. Company Profile

Background

Fluidic Sciences Ltd., established in 2018, is a UK-based company specializing in protein interaction analysis. The company is dedicated to developing transformative in-solution technologies and accessible instruments that enable scientists to understand protein interactions quickly and accurately.

Key Strategic Focus

Fluidic Sciences focuses on enhancing protein biophysical characterization to advance biopharmaceutical research and development. The company's primary product, the Fluidity One-M instrument, utilizes Microfluidic Diffusional Sizing (MDS) technology to measure protein-protein interactions in solution. This technology is particularly beneficial in areas such as membrane protein characterization, vaccine responses, monoclonal therapeutic antibodies, and targeted protein degradation.

Financials and Funding

Fluidic Sciences acquired the assets of Fluidic Analytics Ltd., including the Fluidity One-M instrument, in May 2024. The financial details of this acquisition have not been publicly disclosed.

Pipeline Development

The company's primary product, the Fluidity One-M instrument, is commercially available and has been utilized in various research applications, including profiling immune responses to SARS-CoV-2 variants and studying protein aggregation associated with neurodegenerative diseases.

Technological Platform and Innovation

Fluidic Sciences' proprietary MDS technology offers several advantages:

In-Solution Measurement: Allows direct measurement of protein interactions without the need for immobilization or purification.

Versatility: Capable of analyzing complex mixtures such as serum, cell lysates, or proteins in nanodiscs.

Comprehensive Data: Simultaneously determines protein molecular size, binding affinity, and concentration of binding partners.

Rapid Analysis: Provides a full binding curve and dissociation constant (K_D) within 25 minutes.

Leadership Team

James Wilkinson: Chief Executive Officer

Andrew Lovatt: Executive Director

David Newble: Board Member

Mark Gilligan: Board Member

Nadia Shakir: Product Marketing Manager

Jenny Pham: Marketing Executive

Daniela Penas: Product Specialist

Reuben Reed: Sales & Applications Specialist

Thomas Kavanagh: Sales & Applications Specialist

Riaz Moola: Software Engineer

Yuka Omi: Production Technician

Cristina Mattai del Moro: Office Manager

Robert Ranford: Operations Manager

Annika Gilligan: Web Developer

Leadership Changes

In early 2024, Fluidic Sciences appointed Dr. Andrew Lovatt and Mr. Mark Gilligan as directors, succeeding Robert Daniel Atack.

Competitor Profile

Market Insights and Dynamics

The protein interaction analysis market is experiencing significant growth, driven by advancements in biopharmaceutical research and the increasing need for precise protein characterization tools.

Competitor Analysis

Standard BioTools Inc.: Formerly known as Fluidigm Corporation, this company offers analytical mass cytometry systems and microfluidic arrays for genomic and proteomic analysis.

Gems Sensors & Controls: Specializes in manufacturing application-engineered sensors, including fluidic systems and pressure sensors.

Strategic Collaborations and Partnerships

Fluidic Sciences has established a distribution partnership with M&S TechnoSystems Inc. in Japan to expand its market reach.

Operational Insights

By acquiring the assets of Fluidic Analytics Ltd., Fluidic Sciences has strengthened its position in the protein interaction analysis market, leveraging established technology and an existing customer base to drive growth.

Strategic Opportunities and Future Directions

Fluidic Sciences aims to expand its product offerings and enhance the capabilities of its existing technologies. The company is also focused on entering new markets and forming strategic partnerships to further its mission of advancing protein science.